BERNARDI, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.026
AS - Asia 2.521
EU - Europa 1.449
SA - Sud America 436
AF - Africa 40
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.479
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.960
SG - Singapore 891
HK - Hong Kong 731
CN - Cina 500
BR - Brasile 338
GB - Regno Unito 332
SE - Svezia 292
VN - Vietnam 189
RU - Federazione Russa 169
IT - Italia 135
DE - Germania 109
BG - Bulgaria 92
FI - Finlandia 59
AR - Argentina 44
FR - Francia 38
CA - Canada 32
NL - Olanda 30
ID - Indonesia 26
JP - Giappone 26
PL - Polonia 26
IE - Irlanda 24
AT - Austria 23
BE - Belgio 23
BD - Bangladesh 21
MX - Messico 20
UA - Ucraina 20
IN - India 17
IQ - Iraq 16
KR - Corea 16
EC - Ecuador 13
ES - Italia 13
LT - Lituania 13
TR - Turchia 13
AE - Emirati Arabi Uniti 12
ZA - Sudafrica 12
CO - Colombia 11
CZ - Repubblica Ceca 11
IR - Iran 9
PY - Paraguay 9
EG - Egitto 8
MY - Malesia 8
NO - Norvegia 7
PK - Pakistan 7
VE - Venezuela 7
MA - Marocco 6
RO - Romania 6
CL - Cile 5
IL - Israele 5
KE - Kenya 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
PE - Perù 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
AU - Australia 3
AZ - Azerbaigian 3
CH - Svizzera 3
DZ - Algeria 3
HN - Honduras 3
HU - Ungheria 3
JO - Giordania 3
KG - Kirghizistan 3
RS - Serbia 3
TN - Tunisia 3
BY - Bielorussia 2
CR - Costa Rica 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
SV - El Salvador 2
AM - Armenia 1
BO - Bolivia 1
CD - Congo 1
CV - Capo Verde 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
KH - Cambogia 1
MK - Macedonia 1
MM - Myanmar 1
NI - Nicaragua 1
NP - Nepal 1
PH - Filippine 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
WS - Samoa 1
YT - Mayotte 1
Totale 10.479
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.094
Hong Kong 729
Singapore 605
Ashburn 555
Fairfield 552
Chandler 548
Nyköping 255
London 216
Woodbridge 208
Houston 197
Wilmington 193
Seattle 166
Cambridge 159
Ann Arbor 148
Los Angeles 118
San Diego 114
Beijing 103
New York 101
Chicago 96
Sofia 91
Princeton 90
Ho Chi Minh City 71
Hefei 60
Helsinki 55
Council Bluffs 50
The Dalles 48
Salt Lake City 47
Buffalo 45
Moscow 45
Hanoi 43
Southend 41
São Paulo 40
Shanghai 36
Bremen 33
Jersey City 30
Dearborn 28
Dallas 27
Brussels 23
Dublin 23
Tampa 23
Redondo Beach 21
Jakarta 20
Tokyo 19
Warsaw 19
Phoenix 16
Seoul 16
Frankfurt am Main 15
San Francisco 14
Toronto 14
Elk Grove Village 13
Paris 13
Vienna 13
Bologna 12
Groningen 12
Brno 11
Brooklyn 11
Da Nang 11
Detroit 11
Norwalk 11
Atlanta 10
Denver 10
Jacksonville 10
Milan 10
Montreal 10
Rio de Janeiro 10
Stockholm 10
Chennai 9
Kilburn 9
Modena 9
Orem 9
Sterling 9
Buenos Aires 8
Curitiba 8
Des Moines 8
Falkenstein 8
Haiphong 8
Nuremberg 8
Amsterdam 7
Guangzhou 7
Poplar 7
San Mateo 7
Augusta 6
Boston 6
Chiswick 6
Dong Ket 6
Dulles 6
Eugene 6
Grafing 6
Izmir 6
Jinan 6
Lauterbourg 6
Newark 6
North Charleston 6
Portsmouth 6
Rome 6
Santo André 6
Belo Horizonte 5
Biên Hòa 5
Changsha 5
Charlotte 5
Totale 7.679
Salva come PNG Salva come JPEG
Nome #
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 290
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 259
A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18. 250
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 231
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation 220
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions 218
Adaptive response in Hepatitis B virus infection 202
Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report 182
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C. 169
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 165
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma 160
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis 158
Alcohol and viral hepatitis: a mini-review 149
An in-depth psychosocial and biochemical evaluation in transplant recipients for alcoholic liver disease should be planned 148
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients 147
Chronic hepatitis B: Are we close to a cure? 146
A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of non-responder patients with chronic hepatitic C 146
Acquired intestinal lymphangiectasia successfully treated with a low fat and MCT-enriched diet in a patient with liver transplantation 146
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 145
CD 133+ stem cells for the treatment of end stage liver disease 141
Allocation priority in non urgent liver transplantation: an overview of proposed scoring systems 141
Comparing and combining gamma-hydroxybutiric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomized comparative study 135
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C 134
Characterization of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver 131
Bone marrow derived stem cells for the treatment of end-stage liver disease 127
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? 126
Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from a 20-year multicentre experience in Italy 124
Liver transplantation for patients with alcoholic liver disease: an open question 124
Stem cell mobilization and collection in patients with liver cirrhosis 123
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance 122
Ketoprofen, peginterferon-alpha2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study 121
Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection 120
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool 120
Genetic variability of hepatitis C virus in HBV/HCV co-infection and HCV single-infection 118
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival 117
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B 117
Hepatitis B virus and immune response 116
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels 116
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? 116
In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C 114
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 112
Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report 112
Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection 111
Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen 106
Trattamento dell’epatopatia alcolica 105
Genetic heterogeneity of hepatitis C virus in HBV/HCV co-infection 105
Review article: Alcoholic liver disease - Pathophysiological aspects and risk factors 105
Virological analysis, genotypes and mutational patterns of the HBV pre-core/core gene in HBV/HCV-related hepatocellular carcinoma 103
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation 102
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness 102
Hepatitis C in the elderly: a multicenter cross-sectional study by the Italian Association for the Study of the Liver 99
Hepatocellular carcinoma in patients with cryptogenic cirrhosis 98
OUTCOME OF LIVER TRANSPLANT FOR ALCOHOLIC LIVER DISEASE 97
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 95
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case controlled study 95
Human herpesvirus-8-related Kaposi’s sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin 94
Two yr mycophenolate mofetil plus low-dose calcineurin inhibitor for renal dysfunction after liver transplant 93
Serum hepatitis B surface antigen monitoring in long-term Lamivudine-treated hepatitis B virus patients 93
MARS and Prometheus: our clinical experience in acute chronic liver failure 93
Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin 92
High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? 92
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B 92
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study 92
The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis 92
Post-transplantation lymphoproliferative disorders in liver transplanted patients: a report of four cases 89
Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study 89
Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial 88
GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) ADMINISTRATION IN CIRRHOTIC PATIENTS: A PHASE II STUDY EVALUATING TOLERABILITY PROFILE AND MOBILIZATION OF HAEMATOPOIETIC STEM CELLS (HSCS) 86
Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses 86
ECHO-COLOUR-DOPPLER CHARACTERIZATION OF CIRRHOTIC PATIENTS RESPONDERS AND NON-RESPONDERS TO NADOLOL AS PRIMARY PROPHYLAXIS 85
Role of Contrast-Enhanced Ultrasonography in Primary Hepatic Lymphoma 85
Stem cells for end stage liver disease: How far have we got? 85
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study 84
In portal hypertensive cirrhotic patients abdominal porto-systemic collaterals at ultrasound identify a group of patients at high risk of death 83
MUTATIONAL ANALYSIS OF THE HBV PRE-CORE/CORE GENE IN HBV/HCV-RELATED HEPATOCELLULAR CARCINOMA 82
Vitamins in the treatment of chronic viral hepatitis 82
Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: a phase I clinical trial 82
High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing Lamivudine resistance 82
Hepatic artery stenosis in liver transplanted patients treated with pegylated Interferon alpha-2b and Ribavirin 82
Immunological modifications during treatment with thymosin alpha 1 plus antiviral therapy in chronic hepatitis C 80
PEGYLATED INTERFERON PLUS RIBAVIRIN FOR THE TREATMENT OF RECURRENT HCV INFECTION AFTER LIVER TRANSPLANTATION 78
Sustained and focused HBV-nucleocapsid-specific T cell immunity in liver transplant recipients compared to individuals with chronic and self-limited HBV infection 78
Cryoglobulinemia in elderly patients with HCV-related chronic hepatitis 78
Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophyl granulocytes in patients with liver cirrhosis 77
Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C 77
OUTCOME OF LIVER TRANSPLANT FOR ALCOHOLIC LIVER DISEASE 76
Hepatitis C virus (HCV) infection in elderly patients: A multicenter Italian cross-sectional study 75
Tenofovir-induced Fanconi syndrome in a patient with chronic hepatitis B monoinfection 70
Vitamin E as treatment for chronic viral hepatitis: is it time to perform large clinical trials? 64
Evolution of hepatitis C vitus non structural 5A gene (NS5A) in the progression of liver disease to hepatocellular carcinoma 64
Totale 10.601
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.772
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021788 0 0 0 0 0 31 10 20 396 30 272 29
2021/20221.484 257 134 48 25 11 86 90 85 207 185 193 163
2022/20231.378 188 174 101 137 160 225 11 126 174 4 44 34
2023/2024778 26 47 33 79 217 22 44 122 28 18 28 114
2024/20253.171 117 23 6 238 839 492 116 252 327 178 221 362
2025/20262.549 260 114 387 630 831 327 0 0 0 0 0 0
Totale 10.601